Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > They got rid of their best scientists and their team ie lynn

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Jan 22, 2023 4:30pm

282 Views

Post# 35238753

RE:RE:RE:RE:They got rid of their best scientists and their team ie lynn

Well the PVR was sold for $105M of which LMNL gave 30% away to Kedron. AKA we go ~$73M.

Then we paid off the debt to SALP ~$40M if I recall.

The balance has been slowly pi$$ed away.

Robbed, LOL. You need to join the lawsuit.